Home / Clinical Laboratory / Clinical Analyzer Calibrators and Reagents / Reagents / Starter Pack / Starter Pack Xpert® Molecular Diagnostic C. Difficile/EpiGXCDIFF/EPI-SPAK
Picture of Starter Pack Xpert® Molecular Diagnostic C. Difficile/EpiGXCDIFF/EPI-SPAK

Starter Pack Xpert® Molecular Diagnostic C. Difficile/EpiGXCDIFF/EPI-SPAK

Starter-Pack-Xpert®-Molecular-Diagnostic-C-Difficile-EpiGXCDIFF-EPI-SPAK

SKU #

#1016693

MPN #

GXCDIFF/EPI-SPAK

Brand

Cepheid

Stock

In Stock

Quantity

100

Features

START PAK, XPERT CDIFF/EPI N/SLF ROOM TEMP STRG (100/EA)

$3,472.43 USD

Product Specifications Product Usage Additional Information
Print
Attribute Name Attribute Value
McKesson # 1016693
Manufacturer # GXCDIFF/EPI-SPAK
Brand Xpert®
Manufacturer Cepheid
Application Starter Pack
Test Name C. Difficile/Epi
Test Type Molecular Diagnostic
UNSPSC Code 41116129
Compare Selected Items Email

Similar Items

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

  • Numerous outbreaks caused by the epidemic strain of C. difficile (027/NAP1/BI strain) highlight the need for rapid and accurate differentiation of C. difficile 027/NAP1/BI strains in order to stay ahead of an outbreak
  • Higher risk of cross contamination with 027/NAP1/BI strain due to more efficient sporulation
  • 027/NAP1/BI strain has been identified as a cause of outbreaks around the world
  • Incremental costs due to C. difficile infection can be as high as $7,1799 per patient
  • Xpert C. difficile/Epi is the first commercially available test in the world to detect and differentiate the epidemic strain of C. difficile (027/NAP1/BI). With rapid and accurate identification of the epidemic strain, Infection control professional can stay ahead of potential outbreak
  • Innovative multiplex design enables detection of C. difficile Infection (CDI) and 027/NAP1/BI strain call-out in a single cartridge
  • On-demand testing of samples from suspected CDI patients provides on-demand epidemiological surveillance data clinicians can act on
  • Monitoring and reporting of the epidemic strain enables clinicians to improve infection control efforts
  • Cepheid’s Xpert C. difficile/Epi test provides on demand results you can trust and empowers your clinical team to better manage patients